Cutter Capital Management’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-207,896	Closed	-$5.31M	–	28
2024 Q3	$5.31M	Sell	207,896 -15,089	-7%	-$385K	1.57%	25
2024 Q2	$5.21M	Buy	+222,985	New	+$5.21M	1.57%	23